According to a report in Bloomberg, GlaxoSmithKline is in talks with Qualcomm to create a new joint venture to develop medical technology. Financial Times added in its report that the JV could be worth up to $1 billion.
Very little information about the prospective partnership is available, but it makes sense for both companies: Qualcomm has already teamed up with both Roche and Novartis on major...
